Method for knocking out Endoglin gene by using CRISPR/Cas9 technology
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- GUANGXI MEDICAL UNIVERSITY
- Publication Date
- 2018-08-10
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical fields of genetic engineering, immunology and oncology, and particularly relates to a method for knocking out Endoglin gene by using CRISPR / Cas9 technology and its application. Background technique
[0002] Tumor is an abnormal lesion formed by a certain cell in a local tissue losing its normal regulation of its growth at the gene level under the action of various carcinogenic factors, resulting in its clonal abnormal proliferation. In the late 20th century In the past 30 years, the incidence of cancer has been on the rise. According to the report of the World Health Organization (WHO), the number of new cancer cases in the world in 1990 was about 8.07 million, an increase of 37.4% from 5.17 million in 1975. The number of cancer deaths is about 6.2 million, and according to current trends, as the world population reaches 8 billion by 2020, there will be 20 million new cancer cases, of which the death toll will rea...